Loading...
XNAS
AHCO
Market cap1.36bUSD
Jul 09, Last price  
10.16USD
1D
1.70%
1Q
-16.52%
IPO
1.60%
Name

Adapthealth Corp

Chart & Performance

D1W1MN
XNAS:AHCO chart
P/E
P/S
0.43
EPS
Div Yield, %
Shrs. gr., 5y
20.82%
Rev. gr., 5y
25.16%
Revenues
3.24b
-0.49%
174,316,366192,559,144345,278,337529,644,0001,056,389,0002,454,535,0002,970,595,0003,200,177,0003,260,975,0003,244,857,000
Net income
-71m
L
-3,793,424-6932,086,094-21,341,000-161,632,000156,175,00069,316,000-678,895,00090,422,000-70,794,000
CFO
602m
+11.06%
29,935,20645,930,63468,426,80860,418,000195,634,000275,679,000373,867,000480,666,000541,839,000601,771,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AdaptHealth Corp., alongside its network of subsidiaries, delivers a comprehensive range of home medical equipment (HME), supplies, and associated services across the United States. The company specializes in sleep therapy, providing CPAP and bi-PAP devices and support for individuals managing obstructive sleep apnea. It also furnishes essential medical devices and provisions for diabetes treatment, such as continuous glucose monitors and insulin pumps. AdaptHealth supplies HME to patients transitioning from acute care settings, offers in-home oxygen and chronic therapy services, and caters to chronically ill patients with specialized equipment and supplies for wound care, urological, incontinence, ostomy, and nutritional needs. These services are accessible to beneficiaries of Medicare, Medicaid, and various commercial insurance payors. AdaptHealth Corp. is primarily based in Plymouth Meeting, Pennsylvania.
IPO date
Feb 21, 2018
Employees
10,900
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT